In this week’s Sentinel:
Peter Winter continues to bring us financings and developments in the global diagnostics business. BIO CEO & Investor Conference 2012, held last week in New York City, proved itself one of the most important in the healthcare industry. Intellect Neurosciences, Inc. (OTCBB:ILNS) files new patent applications in the treatment of Alzheimer’s Disease. The CEO of Spherix [SPEX] discusses definitive agreements to sell $1.15 million in common stock and warrants. Contrast-induced nephropathy (CIN), a form of acute renal failure is linked to mortality in hospital patients.
Sincerely,
Brett Johnson